Manocha Monika, Pal Pramod Chandra, Chitralekha K T, Thomas Beena Elizabeth, Tripathi Vinita, Gupta Siddhartha Dutta, Paranjape Ramesh, Kulkarni Smita, Rao D Nageswara
Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi 110029, India.
Vaccine. 2005 Dec 1;23(48-49):5599-617. doi: 10.1016/j.vaccine.2005.06.031. Epub 2005 Jul 27.
The predominant route of HIV infection is through the sexual transmission via M cells. Most of the peptide and protein vaccines show poor transport across the epithelial barrier and are commonly administered by parenteral route. In the present study four HIV peptides from envelope (gp 41-LZ (leucine zipper), gp 41-FD (fusion domain) and gp120-C2) and regulatory (Nef) region in poly lactic-co-glycolide (PLG) micro-particle delivery were evaluated in mice of outbred and with different genetic background to compare immune response versus MHC restriction. Out of the combinational and single routes of immunization attempted, the single route maintained the IgG, IgA and sIgA in sera and washes for longer duration as compared to combinational routes in which the response was declined. The study demonstrated that single intranasal immunization offered significantly higher immune response (p<0.05) over oral and rectal mucosal routes in terms of inducing systemic as well as mucosal response. Also, the specific activity measurement of IgA and IgG in sera and sIgA in washes were correlating to the antibody titers. However, the intramuscular route of immunization generated systemic response only. The entrapment of plant lectin UEA-1 a ligand specific for M cells in micro-particle further enhanced the immune response in all the mucosal routes. The IgG isotypes generated were of IgG1 and IgG2a/2b in sera for all the peptides. The T cell proliferation response study with and without UEA-1 lectin in micro-particles showed significantly high (p<0.05) stimulation index (SI) with intranasal immunization for all the peptides from cells collected from spleen (SP), peyer's patches (PP) and lamina propria (LP) with SI in the order LP cells>PP>or=SP. The cytokine measurement profile of IL-2, IFN-gamma and IL-6 and low levels of IL-4 in the cultural supernatants of SP, PP and LP showed mixed CD4(+) Th1 and Th2 immune response. The p24 assay showed high percent inhibition of HIV-IIIB virus with sera and washes obtained from intranasal route. Thus, overall the study highlighted the combination of UEA-1 lectin with HIV peptides in micro-particles through intranasal immunization generated systemic as well as mucosal immune response.
HIV感染的主要途径是通过M细胞进行性传播。大多数肽类和蛋白质疫苗在穿过上皮屏障方面表现不佳,通常通过肠胃外途径给药。在本研究中,对聚乳酸-乙醇酸共聚物(PLG)微粒递送的来自包膜(gp 41-LZ(亮氨酸拉链)、gp 41-FD(融合结构域)和gp120-C2)及调节(Nef)区域的四种HIV肽在远交系和具有不同遗传背景的小鼠中进行评估,以比较免疫反应与MHC限制。在所尝试的联合免疫途径和单一免疫途径中,与联合免疫途径(其反应下降)相比,单一免疫途径能在更长时间内维持血清和洗液中的IgG、IgA和sIgA。该研究表明,就诱导全身和黏膜反应而言,单次鼻内免疫比口服和直肠黏膜途径产生的免疫反应显著更高(p<0.05)。此外,血清中IgA和IgG以及洗液中sIgA的比活性测量与抗体滴度相关。然而,肌肉注射免疫途径仅产生全身反应。微粒中对M细胞具有特异性的植物凝集素UEA-1的包封进一步增强了所有黏膜途径的免疫反应。所有肽在血清中产生的IgG亚型为IgG1和IgG2a/2b。对微粒中有无UEA-1凝集素的T细胞增殖反应研究表明,对于从脾脏(SP)、派尔集合淋巴结(PP)和固有层(LP)收集的细胞,所有肽通过鼻内免疫均显示出显著高(p<0.05)的刺激指数(SI)(SI顺序为LP细胞>PP≥SP)。SP、PP和LP培养上清液中IL-2、IFN-γ和IL-6的细胞因子测量谱以及低水平的IL-4显示出混合的CD4(+) Th1和Th2免疫反应。p24检测显示,从鼻内途径获得的血清和洗液对HIV-IIIB病毒有较高百分比的抑制作用。因此,总体而言,该研究强调了通过鼻内免疫将UEA-1凝集素与微粒中的HIV肽相结合可产生全身和黏膜免疫反应。